Exeltis is part of the Insud Pharma Group of biopharmaceutical organisations, with over 40 years of experience and operations in more than 50 countries. Exeltis UK was established in 2022 to bring Exeltis products to the UK market, Our product portfolio spans HRT, pregnancy and sexual health, with a healthy pipeline and we are committed to finding clinical solutions to meet the unmet needs for women across key stages of their sexual and reproductive lives.
Dr Diana Mansour
Developments in Progesterone Only Contraception
Dr Melanie Nana
Hyperemesis Gravidarum: What Can Be Done To Improve Patient Outcomes?
Includes an overview of the new RCOG NVP Green Top Guideline
EXE-I/INP-SLY-1303 | Date of Prep MARCH 2024
This webinar will NOT be recorded due to the presentation being the Intellectual Property of the speakers.
The Zoom link to join the event will be emailed to the email address you booked with. This may be received into your spam/junk inboxes, please check.
If you cannot locate the Zoom link, please email webinar@mediconf.co.uk for assistance.
We no longer offer the option to dial in using your phone due to the excessive fees charged.
Find us on LINKEDIN
© Copyright 2007 - 2026 MediConf ©, Inc. All Rights Reserved ©
Registered Office: MediConf Uk c/o LCW Consulting, SWP, Suffolk House, George Street, Croydon, Surrey, CR0 0YN
Registered in England No. 09705397. Company registered in England and Wales. VAT Registration Number: 219014242
Telephone: 01444 414 264
Website design & development by Dual Media Ltd
This site is intended for use by UK healthcare professionals.
Please select the appropriate option below.